Propiedad y actividad de insiders de Kalaris Therapeutics Inc (KLRS): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $3.18 |
| Capitalización | $69M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-08-27 | Vandekop Amy O'Leary | A-Award | 10,000 | $41K |
| 2026-08-01 | KEATING LAURIE | A-Award | 18,000 | $63K |
| 2026-08-01 | KEATING LAURIE | |||
| 2026-07-27 | Vandekop Amy O'Leary | |||
| 2026-07-27 | Vandekop Amy O'Leary | 27,415 | $200K | |
| 2026-07-27 | Vandekop Amy O'Leary | 20,000 | $136K | |
| 2026-07-20 | Bayko Liisa Ann | A-Award | 220,000 | $880K |
| 2026-07-20 | Bayko Liisa Ann | |||
| 2026-06-03 | Jovan-Embiricos Morana | A-Award | 9,000 | $42K |
| 2026-06-03 | Ferrara Napoleone | A-Award | 9,000 | $42K |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $25.0M | $61.1M | $122.7M | $201.7M | $3.1M | $3.2M | $118.3M | $98.1M |
| Inversiones a Corto | 0 | $65.0M | $233.7M | $46.5M | 0 | 0 | 0 | $19.9M |
| Cuentas por Cobrar | $302000 | $560000 | $450000 | $50000 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $25.3M | $127.3M | $361.3M | $253.3M | $3.9M | $3.3M | $118.5M | $118.8M |
| Inmovilizado Material | 0 | $12.1M | $9.5M | $31.3M | 0 | 0 | 0 | $1.5M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $25.3M | $139.4M | $370.8M | $286.6M | $3.9M | $3.3M | $118.5M | $121.7M |
| Cuentas por Pagar | $153000 | $630000 | $963000 | $8.4M | $2.8M | $2.4M | $247000 | $1.3M |
| Deuda a Corto | 0 | $3.1M | $3.2M | $6.6M | 0 | 0 | 0 | $316000 |
| Pasivos Corrientes | $3.7M | $9.1M | $12.3M | $37.9M | $5.7M | $3.9M | $5.2M | $9.7M |
| Deuda a Largo | 0 | 0 | 0 | 0 | $3.3M | 0 | 0 | 0 |
| Pasivos Totales | $3.7M | $17.8M | $17.8M | $61.3M | $34.2M | $48.4M | $5.2M | $42.9M |
| Reservas | -$31.5M | -$55.3M | -$125.1M | -$297.1M | -$32.7M | -$47.4M | -$715.0M | -$160.0M |
| Patrimonio Neto | $21.6M | $121.6M | $353.1M | $225.3M | -$30.3M | -$45.0M | $113.3M | $78.8M |
| Deuda Total | 0 | $11.8M | $8.7M | $30.1M | $3.3M | 0 | 0 | $1.4M |
| Deuda Neta | -$25.0M | -$114.3M | -$347.6M | -$218.1M | $194000 | -$3.2M | -$118.3M | -$116.5M |
| Capital Circulante | $21.6M | $118.2M | $349.0M | $215.5M | -$1.8M | -$609000 | $113.3M | $109.1M |
Salud financiera
| Deuda / Patrimonio | 0.02 |
| Ratio corriente | 10.98 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -0.21 |
Rentabilidad
| Rentabilidad sobre capital | -71.71% |
| Rentabilidad sobre capital invertido | -52.40% |
| Rentabilidad sobre activos | -44.47% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ARTV · CNTB · CNTX · IFRX · IMA · MGX · OVID
Explorar sector: Healthcare · Biotechnology
Más secciones de KLRS: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones